OKYO Pharma Limited
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-165.37-1.68K-5.70K-49.03-379.46-1.39K-726.23-652.68-2.81-2.56K-4.73-379.46
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
40.2743.11N/AN/A5.58K-15.41K457.831.20K-18.21-7.3334.91-15.41K
Price/Cash Flow ratio
-963.09-2.11K-2.11K-869.05-934.86-1.79K-1.52K-648.26-4.85-4.54-4.70-934.86
Price/Free Cash Flow ratio
-326.82-1.30K-1.34K-869.05-934.24-1.79K-1.51K-648.06-4.85-4.54-4.70-934.24
Price/Earnings Growth ratio
3.1318.7078.42-0.004.3519.24-7.86-65.26-0.0025.660.0319.24
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-452.41%18.80%23.53%N/A3.50%4.70%0.73%12.65%0.09%-0.13%12.65%3.50%
Return on Assets
-24.24%-2.54%N/AN/A-645.18%-258.14%-47.29%-126.28%-255.03%-1.09%-505.14%-645.18%
Return On Equity
-24.35%-2.56%N/AN/A-1471.60%1103.11%-63.04%-184.26%646.37%0.28%-541.16%-1471.60%
Return on Capital Employed
-5.16%-3.51%N/AN/A-1362.62%1341.01%-76.77%-210.95%642.26%0.26%-843.80%-1362.62%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A3.17N/A
Quick Ratio
44.9529.61N/AN/A1.770.794.093.170.710.202.641.77
Cash ratio
42.7928.28N/AN/A1.470.334.031.990.550.111.991.47
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A209.68-48.410.94-224.60N/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/A635.78K29.33K5.88K77.98K98.41K213.65KN/A29.33K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/A0.34N/A0.31N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-0.87N/A0.45N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/A-6.96N/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-4.28N/AN/AN/A
Company Equity Multiplier
1.001.00N/AN/A2.28-4.271.331.45-2.53-0.261.45-4.27
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
2.941.621.5711.0011.001.001.0011.001
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-4.28N/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-4.28N/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A